Full-Time

Data Governance Specialist

Piper Sandler

Piper Sandler

1,001-5,000 employees

Compensation Overview

$100k - $200k/yr

+ Annual Incentive

New York, NY, USA + 1 more

More locations: Minneapolis, MN, USA

In Person

Category
Data & Analytics (1)
Required Skills
Data Lake
Role-based Access Control
Data Governance
Requirements
  • 5+ years of experience in data governance or data operations within a fast-paced, dynamically growing organization
  • Strong knowledge of data-driven processes, products, technology, and controls in an enterprise setting
  • Track record of leading data governance and data transformation initiatives across business and IT functions
  • Experience establishing and managing a new data governance function and data capabilities
  • Demonstrated hands-on experience with data governance platforms and tools
  • Expert problem solver with the ability to identify and triage data issues and drive tactical and strategic solutions
  • Strong communication and influencing skills with partners and peers at all levels of the organization
  • Strategic thinker with the ability to recognize and take actions that maximizes value for the organization
Responsibilities
  • Develop and maintain a comprehensive data governance framework, including policies, standards, and processes for data quality, data privacy, data security, data lifecycle management, and metadata management
  • Set the standard for data governance and data quality and formalize best data operating practices for adoption by the firm
  • Provide data governance expertise to strategic projects, business initiatives and operational changes
  • Identify and shape continuous improvement opportunities and recommendations that drive data to better serve the growing business
  • Provide thought leadership for data governance and data health with our business lines
  • Act as a primary point of contact for all data governance-related inquiries
  • Directly manage and maintain data catalog, metadata management, data quality, and data lineage tools
  • Lead data remediation efforts, working with data owners and technical teams to resolve data quality and integrity issues
  • Implement and enforce data access policies within data platforms (e.g., data lakes, data warehouses, databases), ensuring role-based access control (RBAC) and compliance with data privacy regulations
  • Research, evaluate, and propose new data governance tools and technologies that can enhance the program's efficiency and effectiveness
  • Develop and track key performance indicators (KPIs) and metrics to measure the effectiveness of the data governance program
  • Establish cross functional partnerships with Development Team to find opportunities to leverage data to enrich existing or new applications
  • Collaborate with legal, compliance, security, and business units to ensure adherence to regulatory requirements (e.g., GDPR, CCPA, HIPAA) and internal policies
  • Work with product and engineering leadership, key stakeholders, data owners and data stewards, to build consensus through effective communications of well-analyzed business cases and supporting materials

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Minneapolis, Minnesota

Founded

1895

Simplify Jobs

Simplify's Take

What believers are saying

  • Tenth consecutive quarter of year-over-year revenue growth reaching record $470 million.
  • Corporate investment banking revenues surged 30% year-over-year to $324 million record.
  • Operating margin expanded to 20% as operating income grew 37% year-over-year.

What critics are saying

  • Healthcare franchise over-reliance collapses if FDA accelerates AI-driven drug approvals.
  • Talent drain to Wells Fargo and Goldman Sachs erodes mid-market M&A ranking.
  • Merchant banking investments like Paragon 28 dilute shareholder value amid cooling M&A.

What makes Piper Sandler unique

  • Ranked #2 in US mid-market M&A deals under $2 billion with record healthcare revenues.
  • Expanded to record 192 investment banking managing directors with specialized healthcare expertise.
  • Bookrunner on all 23 biopharma equity deals priced in Q1 2026.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Piper Sandler who can refer or advise you

Benefits

Wellness Program

Company News

Yahoo Finance
Apr 14th, 2026
Piper Sandler downgrades SAP, Asana and Monday.com as AI transition strains software sector

Piper Sandler has downgraded several enterprise software stocks as companies struggle to monetise artificial intelligence amid macroeconomic pressures. Germany's SAP was cut to "neutral" from "overweight", with its price target reduced to €170 from €220, citing slower-than-expected cloud conversions as chief information officers prioritise AI adoption over traditional ERP migrations. SAP's significant exposure to Europe, the Middle East and Africa — approximately 46% of fiscal 2025 revenue — leaves it vulnerable to regional economic pressures. Analysts noted the sector is undergoing a "SaaS to AI transition" on a compressed timeline, with meaningful AI revenue contributions expected to take time. Collaboration software firms Asana and Monday.com were also downgraded to "neutral", with price targets of $7 and $85 respectively, facing slowing seat expansion and moderating growth.

SGB Online
Apr 9th, 2026
Crocs' former IR chief joins Helly Hansen as Head of Finance and Operations.

Crocs' former IR chief joins Helly Hansen as Head of Finance and Operations. April 9, 2026 Kontoor Brands Inc. (KTB) reports that Erinn Murphy, formerly at Crocs, will join the company in early May as VP and global head of Finance and Operations for Helly Hansen and corporate investor relations. As a member of Helly Hansen's leadership team, Murphy will take an international assignment in Oslo, Norway, overseeing KTB's corporate investor relations. Murphy joins Kontoor from Crocs Inc., where she served as senior vice president, Investor Relations and Corporate Strategy. Prior to that, Murphy served as managing director of Consumer Equity Capital Markets for Piper Sandler. She was recently appointed to the board of Revolve Group, Inc. Murphy's appointment coincides with an expanded role for Michael Karapetian, who will serve as vice president of Global Brand and Operations Finance and Corporate Investor Relations, with responsibility for Global Brand and Supply Chain Finance and corporate investor relations. Karapetian will return from his international assignment at Helly Hansen in the third quarter of 2026 to allow for a transition period. The hiring of Murphy was announced a day after Kontoor reported that Joseph Alkire, who, in addition to his responsibilities as chief financial officer and global head of operations, will assume global responsibilities for the Helly Hansen brand, effective immediately. Børre Hegbom will continue as SVP and Global Head of Helly Hansen. Formerly Helly Hansen's managing director of Sport, Hegbom was promoted to that role last October. Kontoor, which also owns Wrangler and Lee, acquired Helly Hansen in June 2025. Images courtesy Helly Hansen and Crocs, Inc.

Yahoo Finance
Mar 30th, 2026
Piper Sandler initiates coverage on Dime Community Bancshares with $37 target and overweight rating

Piper Sandler initiated coverage of Dime Community Bancshares, Inc. (NASDAQ:DCOM) with an Overweight rating and a $37 price target on 16 March. The firm expects continued recovery in net interest margin, supported by significant loan repricing over 2026 and 2027. During the Q4 2025 earnings call, CEO Stuart Lubow reported core earnings per share of $0.79, up 88% year-on-year, driven by record quarterly revenue of $124 million. Core deposits increased by $1.2 billion year-on-year, whilst business loans rose over $500 million compared to the prior year. Dime Community Bancshares operates through its subsidiary, Dime Community Bank, providing commercial and consumer banking services. The company is targeting an efficiency ratio below 50% for 2026.

Business Wire
Mar 27th, 2026
Secretome Therapeutics announces participation in upcoming investor conferences.

Secretome Therapeutics announces participation in upcoming investor conferences. PLANO, Texas-(BUSINESS WIRE)-Secretome Therapeutics, a clinical-stage biotechnology company developing novel cellular and cell-based therapies derived from neonatal cardiac progenitor cells (nCPCs), today announced its participation in three upcoming investor conferences and meetings focused on the biopharma sector. Secretome is scheduled to participate in Guggenheim Securities' Healthcare Private Biopharma Company Virtual 1x1 Day on March 31, 2026, and Piper Sandler's Spring Biopharma Symposium in Boston on April 15-16, 2026. "These invitations reflect growing interest in Secretome's platform and development strategy as we continue advancing STM-01 and our broader pipeline," said Vinny Jindal. "We appreciate the opportunity to engage with investors and industry participants as we work to bring novel therapies forward for patients with serious unmet medical needs." Secretome is advancing STM-01 for Duchenne muscular dystrophy-associated cardiomyopathy (DMD-CM), the lead indication for the company's flagship program.Secretome expects to initiate Phase 2 in the second quarter of 2026 and is concurrently preparing for its pivotal Phase 3 program. About Secretome Therapeutics Secretome Therapeutics is a clinical-stage biotechnology company developing novel therapies derived from neonatal cardiac progenitor cells (nCPCs) for orphan and underserved chronic diseases. Its lead program, STM-01, is being advanced for Duchenne muscular dystrophy-associated cardiomyopathy (DMD-CM), alongside a broader pipeline of nCPC-based therapeutic programs. Forward-Looking Statements This press release contains forward-looking statements, including statements regarding anticipated conference participation, future corporate updates, development timing, and planned clinical and regulatory milestones. Actual results may diXer materially from those expressed or implied by these forward-looking statements due to a variety of risks and uncertainties.

Paragon 28
Mar 26th, 2026
Paragon 28 Completes Series B Financing with Piper Sandler Merchant Banking and MVM Partners

Paragon 28, Inc., a leading orthopedic foot and ankle company, today announced the completion of a Series B financing.  The round was co-led by Piper Sandler Merchant Banking, a commercial stage growth equity investment business of Piper Sandler Companies, and MVM Partners, a healthcare growth equity investment firm.  The financing also included participation from an existing Series A investor. Read the full article here.